Expression of antimicrobial peptides and toll-like receptors is increased in tinea and pityriasis versicolor

Mycoses

Volumn 57, Issue 3, 2014, Pages 147-152

  Brasch, J ^a   Morig A ^a   Neumann, B ^a   Proksch, E ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Dectin; Defensins; Dermatophytes; Malassezia; Psoriasin; Toll like receptors

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 2; BETA DEFENSIN 3; DECTIN 2; PSORIASIN; RIBONUCLEASE; RIBONUCLEASE 7; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DERMATOPHYTE; EPIDERMIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SKIN BIOPSY; STRATUM CORNEUM; TINEA; TINEA VERSICOLOR; TRICHOPHYTON RUBRUM;

DECTIN; DEFENSINS; DERMATOPHYTES; MALASSEZIA; PSORIASIN; TOLL-LIKE RECEPTORS;

BETA-DEFENSINS; HUMANS; LECTINS, C-TYPE; RETROSPECTIVE STUDIES; RIBONUCLEASES; S100 PROTEINS; SKIN; TINEA; TINEA VERSICOLOR; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TRICHOPHYTON;

EID: 84893521561     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12118     Document Type: Article

References (18)

1. Sawamura D, Goto M, Shibaki A et al. Beta defensin-3 engineered epidermis shows highly protective effect for bacterial infection. Gene Ther 2005; 12: 857-61.
2. De Jongh GJ, Zeeuwen PLJM, Kucharekova M et al. High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol 2005; 125: 1163-73.
3. Zanger P, Holzer J, Schleucher R, Steffen H, Schittek B, Gabrysch S. Constitutive expression of the antimicrobial peptide RNase 7 is associated with Staphylococcus aureus infection of the skin. J Infect Dis 2009; 200: 1907-15.
4. Zheng Y, Niyonsaba F, Ushio H et al. Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation. Immunology 2008; 124: 357-67.
5. Akira S. Toll-like receptor signaling. J Biol Chem 2003; 278: 38105-8.
6. Saijo S, Iwakura Y. Dectin-1 and Dectin-2 in innate immunity against fungi. Int Immunol 2011; 23: 467-72.
7. Gläser R, Meyer-Hoffert U, Harder J et al. The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol 2009; 129: 641-9.
8. Holm S. A simple sequentially rejective multiple test procedure. Scand J Statistics 1979; 6: 65-70.
9. Curry JL, Qin J-Z, Bonish B et al. Innate immune-related receptors in normal and psoriatic skin. Arch Pathol Lab Med 2003; 127: 178-86.
10. Kiemer AK. Angeborenes Immunsystem. TLR eröffnen neue Möglichkeiten. Pharmazeutische Zeitung. http://www.pharmazeutische-zeitung.de/index.php?id=4546(online 04/2008).
11. Bauer S, Kirschning CJ, Häcker H et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 2001; 98: 9237-42.
12. Criado PR, de Oliveira CB, Dantas KC, Takiguti FA, Benini LV, Vasconcellos C. Superficial mycosis and the immune response elements. An Bras Dermatol 2011; 86: 726-31.
13. Gambichler T, Skrygan M, Tomi NS et al. Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin. Int Arch Allergy Immunol 2008; 147: 17-24.
14. Proksch E, Brasch J. Barrier function, epidermal differentiation, and human beta- defensin 2 expression in tinea corporis. J Invest Dermatol 2007; 127: 1720-7.
15. Gläser R, Köten B, Wittersheim M, Harder J. Psoriasin: key molecule of the cutaneous barrier? J Dtsch Dermatol Ges. http://www.ncbi.nlm.nih.gov/pubmed/21501383
16. Schröder J-M, Harder J. Human beta-defensin-2. Int J Biochem Cell Biol 1999; 31: 645-51.
17. Schröder JM, Harder J. Antimicrobial skin peptides and proteins. Cell Mol Life Sci 2006; 63: 469-86.
18. Fritz P, Beck-Jendroschek V, Brasch J. Inhibition of dermatophytes by the antimicrobial peptides human β-defensin-2, ribonuclease 7 and psoriasin. Med Mycol 2012; 50: 579-84.